Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Brain & Neurology

Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations

The evidence is considered of moderate benefit for duloxetine. Photobiomodulation, known as low level laser therapy, is considered of moderate benefit based on the evidence review.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors reviewed 35 studies of treatments for chemotherapy-induced peripheral neuropathy published from 1990 to 2017. They report moderate evidence of benefit for duloxetine and for photobiomodulation (low level laser therapy), while evidence did not support lamotrigine or topical ketamine-amitriptyline. Most included studies had small samples and short follow-up.

Studies included
35
Who or what was studied
Patients with chemotherapy-induced peripheral neuropathy
Limits stated in the abstract
Included studies were small, had short follow-up, and varied widely in timing of treatment, primary outcomes, and chemotherapy agents used.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.

Record from PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Neuropathy, Systematic review, Laser, Photobiomodulation, Primary outcome, Risk of bias, GRADE. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies